FOXO3 and cancer: The induction of autophagy-mediated cancer resistance mechanism after therapeutic approaches is attributed to reduced mTOR activity (Amaravadi et al., 2011), or to turnover of FOXO3A that reduced apoptosis by preventing FOXO3A-dependent induction of Puma, a BH3 proapoptotic protein (Fitzwalter et al., 2018).